109906
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
傅氏皮下针法治疗疼痛：随机对照试验的系统评价和荟萃分析
Authors Gong X , Wu F, Guo Z, Li N , Wang Z, Liu D
Received 20 June 2025
Accepted for publication 18 October 2025
Published 31 October 2025 Volume 2025:18 Pages 5739—5752
DOI https://doi.org/10.2147/JPR.S544998
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Houman Danesh
Xiaogang Gong,1 Fengzhi Wu,2 Zhenyu Guo,2 Na Li,3 Zhiyong Wang,4 Dongming Liu1
1Department of Medicine, College of Special Education, Beijing Union University, Beijing, People’s Republic of China; 2School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 3School of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 4Department of Human Anatomy and Histoembryology, School of Basic Medical Sciences, Peking University, Beijing, People’s Republic of China
Correspondence: Dongming Liu, Department of Medicine, College of Special Education, Beijing Union University, Beijing, People’s Republic of China, Email dongming@buu.edu.cn
Purpose: To evaluate the efficacy and safety of Fu’s subcutaneous needling (FSN) for pain management using randomized controlled trials (RCTs), to provide evidence-based guidance for clinical practice and future research.
Methods: A systematic literature search was conducted of PubMed, Embase, Scopus, Cochrane Library, Clinical Trials.gov, and Web of Science databases for RCTs published from inception to May 15, 2025. To be included, studies were required to compare FSN with control interventions for treating pain in adults. Study quality was assessed using the Cochrane Risk of Bias tool, and meta-analysis was performed using RevMan 5.4. Outcomes included pain intensity, and pain-related and functional outcomes.
Results: Eight RCTs (n = 519 participants) were included. Compared with controls, FSN was more effective at reducing pain, with a pooled mean difference (MD) of − 1.14 (95% confidence interval [CI]: − 1.34 to − 0.95; P < 0.001) on the visual analog scale. Subgroup analyses confirmed sustained benefits at the 15-day follow-up (MD = − 1.79; P < 0.001) and 1-month follow-up (MD = − 1.08; P < 0.001) time-points. Secondary outcomes included significant improvements in the Oswestry Disability Index (MD = − 6.10; P < 0.001), range of motion (MD = 9.11; P < 0.001), Lysholm score (standardized MD [SMD] = 0.66; P < 0.001), and 36-Item Short-Form Survey (SMD = 0.78; P < 0.001). Adverse events were mild and transient, with no serious adverse effects reported.
Conclusion: FSN is an effective and safe intervention for pain management, and results in greater pain reduction and functional improvement than other non-pharmacological interventions. Future studies should prioritize multicenter RCTs with standardized protocols, extended follow-up, and diverse populations to confirm the long-term efficacy of FSN for pain management.
Keywords: Fu’s subcutaneous needling, pain management, meta-analysis, systematic review, randomized controlled trial
1Department of Medicine, College of Special Education, Beijing Union University, Beijing, People’s Republic of China; 2School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 3School of Acupuncture, Moxibustion and Tuina, Beijing University of Chinese Medicine, Beijing, People’s Republic of China; 4Department of Human Anatomy and Histoembryology, School of Basic Medical Sciences, Peking University, Beijing, People’s Republic of China
Correspondence: Dongming Liu, Department of Medicine, College of Special Education, Beijing Union University, Beijing, People’s Republic of China, Email dongming@buu.edu.cn
Purpose: To evaluate the efficacy and safety of Fu’s subcutaneous needling (FSN) for pain management using randomized controlled trials (RCTs), to provide evidence-based guidance for clinical practice and future research.
Methods: A systematic literature search was conducted of PubMed, Embase, Scopus, Cochrane Library, Clinical Trials.gov, and Web of Science databases for RCTs published from inception to May 15, 2025. To be included, studies were required to compare FSN with control interventions for treating pain in adults. Study quality was assessed using the Cochrane Risk of Bias tool, and meta-analysis was performed using RevMan 5.4. Outcomes included pain intensity, and pain-related and functional outcomes.
Results: Eight RCTs (n = 519 participants) were included. Compared with controls, FSN was more effective at reducing pain, with a pooled mean difference (MD) of − 1.14 (95% confidence interval [CI]: − 1.34 to − 0.95; P < 0.001) on the visual analog scale. Subgroup analyses confirmed sustained benefits at the 15-day follow-up (MD = − 1.79; P < 0.001) and 1-month follow-up (MD = − 1.08; P < 0.001) time-points. Secondary outcomes included significant improvements in the Oswestry Disability Index (MD = − 6.10; P < 0.001), range of motion (MD = 9.11; P < 0.001), Lysholm score (standardized MD [SMD] = 0.66; P < 0.001), and 36-Item Short-Form Survey (SMD = 0.78; P < 0.001). Adverse events were mild and transient, with no serious adverse effects reported.
Conclusion: FSN is an effective and safe intervention for pain management, and results in greater pain reduction and functional improvement than other non-pharmacological interventions. Future studies should prioritize multicenter RCTs with standardized protocols, extended follow-up, and diverse populations to confirm the long-term efficacy of FSN for pain management.
Keywords: Fu’s subcutaneous needling, pain management, meta-analysis, systematic review, randomized controlled trial